Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
CGON: CG Oncology Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
CGON
The Story
CGON
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Operating margin
-4239.0%
ROIC
-19.5%
Financially safe
Stretched
Debt / equity
0.01×
Interest coverage
0.0×
Current ratio
31.30×
CG Oncology Inc.
CGON
NASDAQ
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
CG Oncology Inc.
CGON
NASDAQ
·
USD
·
Closed
$71.19
−2.52%
$71.19
−$1.84 (2.52%)
52W Range
89th
pctl
Volume
0.53×
avg
Mkt Cap
6.28B
USD
P/E
-30.4
TTM
Div Yield
–
ann
52W Range
89th
pctl
Volume
0.53×
avg
Market Cap
6.28B
USD
P/E Ratio
-30.4
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings